🦊/Companies

페프로민바이오

Irvine, US · 1 known investors

Find your way into 페프로민바이오

PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.

Founders & leadership

NH
Nicolas HwangChief Executive Officer
AP
Andrew ParkChief Financial Officer

Investors · 1

Competitors · 3

by search overlap

Companies competing with 페프로민바이오 for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does 페프로민바이오 do?
PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.
Who are 페프로민바이오's investors?
페프로민바이오's investors include Solidus Investment.
Where is 페프로민바이오 headquartered?
페프로민바이오 is headquartered in Irvine, US.